Qiong Zhang Selected Research

hydroxysafflor yellow A

8/2021	Corrigendum to "Hydroxysafflor yellow A inhibits hypoxia/reoxygenation-induced cardiomyocyte injury via regulating the AMPK/NLRP3 inflammasome pathway" [Int. Immunopharm. 82 (2020) 106316].
1/2021	Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
1/2021	Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy.
2/2020	Hydroxysafflor yellow A inhibits hypoxia/reoxygenation-induced cardiomyocyte injury via regulating the AMPK/NLRP3 inflammasome pathway.
1/2020	Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiong Zhang Research Topics

Disease

81	Neoplasms (Cancer) 03/2022 - 02/2006
41	Hypoxia (Hypoxemia) 01/2022 - 06/2006
28	Infections 07/2022 - 07/2007
27	Inflammation (Inflammations) 07/2022 - 07/2008
16	Burns 01/2019 - 10/2007
14	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2006
11	Wounds and Injuries (Trauma) 01/2020 - 01/2012
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
10	Neoplasm Metastasis (Metastasis) 04/2021 - 01/2013
9	COVID-19 01/2022 - 07/2020
8	Reperfusion Injury 01/2021 - 08/2014
7	Necrosis 05/2022 - 03/2010
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2012
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 04/2015
6	Carcinogenesis 01/2021 - 02/2007
6	Pre-Eclampsia (Preeclampsia) 07/2019 - 08/2014
5	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2017
5	Endometriosis 11/2021 - 11/2017
5	Coronary Disease (Coronary Heart Disease) 07/2021 - 09/2005
5	Proteinuria 01/2021 - 11/2016
5	Stomach Neoplasms (Stomach Cancer) 01/2019 - 04/2009
5	Lymphatic Metastasis 03/2018 - 08/2013
4	Starvation 08/2022 - 05/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022 - 01/2018
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2010
4	Virus Diseases (Viral Diseases) 01/2021 - 01/2013
4	Fibrosis (Cirrhosis) 01/2021 - 05/2017
4	Glioma (Gliomas) 01/2021 - 02/2018
4	Type 2 Diabetes Mellitus (MODY) 03/2020 - 01/2013
4	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 03/2015
4	Edema (Dropsy) 06/2019 - 01/2015
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2015
4	Diabetes Mellitus 01/2019 - 01/2013
4	Hypertension (High Blood Pressure) 01/2018 - 04/2014
4	Body Weight (Weight, Body) 01/2018 - 12/2011
4	Parkinson Disease (Parkinson's Disease) 01/2015 - 07/2013
3	Hemorrhage 06/2022 - 06/2020

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2009
22	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2012
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
17	CytokinesIBA 01/2022 - 12/2003
15	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2010
15	Pharmaceutical PreparationsIBA 01/2022 - 02/2004
14	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2009
12	EnzymesIBA 03/2020 - 04/2008
11	Biological ProductsIBA 08/2022 - 04/2015
11	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2005
11	Long Noncoding RNAIBA 01/2022 - 01/2018
10	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2013
10	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 06/2007
10	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020 - 01/2010
10	salicylhydroxamic acid (SHAM)IBA 01/2020 - 07/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 02/2009
7	LipidsIBA 12/2021 - 10/2015
7	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2010
7	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2016 - 06/2006
6	Therapeutic UsesIBA 10/2021 - 02/2004
6	InflammasomesIBA 08/2021 - 09/2018
6	ResveratrolIBA 01/2021 - 05/2014
6	Insulin (Novolin)FDA Link 03/2020 - 12/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2012
6	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2008
5	CateninsIBA 07/2022 - 01/2015
5	LipopolysaccharidesIBA 07/2022 - 03/2015
5	CadmiumIBA 11/2021 - 08/2014
5	hydroxysafflor yellow AIBA 08/2021 - 01/2020
5	Vascular Endothelial Growth Factor BIBA 01/2021 - 05/2014
5	AntigensIBA 01/2019 - 07/2007
5	rho-Associated KinasesIBA 12/2016 - 11/2014
5	Adenosine Triphosphate (ATP)IBA 10/2016 - 06/2007
5	fasudil (AT 877)IBA 01/2016 - 11/2014
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2022 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 12/2008
4	CreatinineIBA 01/2021 - 01/2016
4	CalciumIBA 01/2021 - 06/2008
4	Blood Glucose (Blood Sugar)IBA 03/2020 - 07/2011
4	Oxygen (Dioxygen)IBA 01/2020 - 07/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2019 - 12/2003
4	NF-kappa B (NF-kB)IBA 12/2017 - 12/2003
4	Interleukin-10 (Interleukin 10)IBA 03/2017 - 12/2003
4	Caspase 3 (Caspase-3)IBA 01/2017 - 06/2008
4	AntioxidantsIBA 01/2017 - 01/2012
4	ErbB Receptors (EGF Receptor)IBA 04/2015 - 02/2006
4	Colchicine FDA LinkGeneric 04/2015 - 06/2007
4	PlacebosIBA 08/2014 - 07/2010
4	Interleukin-17 (Interleukin 17)IBA 01/2014 - 07/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2012 - 06/2006
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2022 - 01/2016
3	Histones (Histone)IBA 03/2022 - 02/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 04/2017
3	Retinaldehyde (Retinal)IBA 01/2022 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2004
3	ChemokinesIBA 01/2022 - 11/2012
3	MelatoninIBA 11/2021 - 01/2016
3	Matrix Metalloproteinases (MMPs)IBA 08/2021 - 10/2013

Therapy/Procedure

33	Therapeutics 07/2022 - 12/2008
10	Drug Therapy (Chemotherapy) 01/2021 - 04/2009
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2013
5	Immunotherapy 01/2021 - 12/2008
4	Operative Time 06/2022 - 01/2019